PRECLINICAL STUDIES ON NONHUMAN PRIMATE ENDOMETRIAL XENOGRAFTS

非人灵长类子宫内膜异种移植物的临床前研究

• 批准号: 8357758
• 负责人: OV D SLAYDEN
• 金额: $ 7.28万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357758
• 关键词: Agonist; Endocrine Glands; Endometrial; Endometrium; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Funding; Goals; Grant; Growth; Lesion; Macaca; Modeling; Mus; National Center for Research Resources; Primates; Principal Investigator; Reporting; Research; Research Infrastructure; Resources; SCID Mice; Selective Estrogen Receptor Modulators; Site; Source; Testing; Tissues; Transplantation; United States National Institutes of Health; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Woman; Xenograft procedure; cost; endometriosis; inhibitor/antagonist; nonhuman primate; preclinical study; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Endometriosis is a condition where endometrium-like tissue forms lesions at sites outside the uterus. Our goal is to test potential therapies for endometriosis. To do this we have developed a model in which macaque endometrium is transplanted into immunodeficient SCID mice, which are incapable of rejecting xenografts. The endometrial xenografts grow in response to estradiol (E2) and undergo cyclic breakdown similar to endometriosis in women. We tested the effects of three antiestrogenic (anti estrogen receptor alpha) selective estrogen receptor modulators (SERMs) and report that these SERMS suppress growth of ectopic macaque endometrium. We also tested 3 proprietary ER beta agonists provided by Bayer Schering Pharma AG and report that ER beta agonists do not inhibit the establishment of ectopic endometrium in these mice. We then tested inhibitors of vascular endothelial growth factor (VEGF)-A and endocrine gland (EG)-VEGF, and report that both inhibitors blocked graft acceptance and growth.

这个子项目是利用这些资源的众多研究子项目之一